KRYS
Krystal Biotech, Inc. Common Stock#24 · 2019EPBYearly return
+143%
Peak return
+191%
Max drawdown
-44%
ADR (20 days)
+7.2%
Base
29 days / -43.5%
Prior run
+111%
Breakout volume
14.0x
Pivot
$35.19
Catalyst Unternehmensmeldung2019-06-248-K Reg-FD-Mitteilung (Item 7.01), Krystal Biotech, Inc.SEC EDGAR
Offizielle Unternehmensmitteilung im Umfeld des Ausbruchs. Beleg: offizielles 8-K-Filing bei der SEC.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare KRYS with the current market directly.